Videos

Breaking Down Health Care

Why People Should Care About How Health Care Works (Part 1)

07/29/2024

In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dive into the topic of big data: what it is, how it came about, and why we’re still struggling to leverage it.

In part one of this two-part...

07/29/2024

Cancer Care Business Exchange

Videos

Evaluating the Efficacy of R-Mini-CHOP With or Without Oral Azacytidine for Elderly Patients With DLBCL

07/29/2024

Elizabeth Brem, MD, shares expert insight into a clinical trial examining elderly patients with DLBCL treated with rituximab and reduced dose cyclophosphamide, hydroxydaunorubicin, vincristine sulfate, and prednisone with or without oral...

Elizabeth Brem, MD, shares...

07/29/2024

Oncology

Videos

CAR T-Cell Therapy vs Other Novel Therapies for Elderly Patients With Relapsed DLBCL

07/29/2024

At the 2024 Great Debates & Updates meeting, Elizabeth Brem, MD, shares expert insight on the role of CAR T-cell therapies versus other novel therapies for treating older patients with relapsed diffuse large B-cell lymphoma.

At the 2024 Great Debates &...

07/29/2024

Oncology

Videos

Benefits of Utilizing CAR-T in Later Lines of Therapy for Patients With Multiple Myeloma

07/28/2024

At the 2024 Great Debates & Updates meeting, Rahul Banerjee, MD, participated in a debate in which he argued against the use of CAR T-cell therapy in earlier lines of therapy among patients with multiple myeloma.

At the 2024 Great Debates &...

07/28/2024

Oncology

Videos

Should Autologous Stem Cell Transplantation be Considered for Older Patients With Multiple Myeloma?

07/28/2024

At the 2024 Great Debates & Updates meeting, Amrita Krishnan, MD, argued for the value of considering autologous stem cell transplantation for certain patients over the age of 65, emphasizing the benefit of assessing frailty as a complex and...

At the 2024 Great Debates &...

07/28/2024

Oncology

Videos

Should Minimal Residual Disease Guide Therapy for Patients With Multiple Myeloma?

07/28/2024

At the 2024 Great Debates & Updates meeting, Murali Janakiram, MD, MS, participated in a debate about the value of MRD assessment in the treatment and management of multiple myeloma.

At the 2024 Great Debates &...

07/28/2024

Oncology

Videos

Examining Risk Stratification and Novel Treatment Options for Patients With Low and Intermediate-Risk MDS

07/28/2024

Pinkal Desai, MD, discusses risk stratification, restructured disease classifications, and current treatment options for patients with low and intermediate-risk myelodysplastic syndrome at the 2024 Great Debates & Updates meeting.

Pinkal Desai, MD, discusses risk...

07/28/2024

Oncology

Videos

Assessing the Impact of FDA Approval of Pirtobrutinib in the R/R Chronic Lymphocytic Leukemia Treatment Landscape

07/28/2024

Inhye Ahn, MD, shares insight into the real-world practice impact of the FDA approval of non-covalent Bruton tyrosine kinase inhibitor pirtobrutinib for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who have...

Inhye Ahn, MD, shares insight...

07/28/2024

Lymphoma, Leukemia & Myeloma Network

Videos

Investigating Next Steps for Pirtobrutinib Therapy Among Patients With Chronic Lymphocytic Leukemia

07/28/2024

Inhye Ahn, MD, discusses next steps for investigating applications of pirtobrutinib in the current treatment paradigm for patients with chronic lymphocytic leukemia.

Inhye Ahn, MD, discusses next...

07/28/2024

Lymphoma, Leukemia & Myeloma Network

Videos

Novel Developments in the Frontline and Relapsed/Refractory Mantle Cell Lymphoma Treatment Landscape

07/28/2024

Tycel Phillips, MD, reviews the latest updates and developments in both the frontline and relapsed/refractory treatment landscape for patients with mantle cell lymphoma.

Tycel Phillips, MD, reviews the...

07/28/2024

Lymphoma, Leukemia & Myeloma Network